Literature DB >> 31413084

Performance of Five Commercial Identification Platforms for Identification of Staphylococcus delphini.

David A Bemis1, Karen C Carroll2, Lars F Westblade3,4, Matthew C Canver5, Tsigereda Tekle6, Samantha T Compton1, Katrina Callan5, Eileen M Burd7, Barbara L Zimmer8.   

Abstract

The Staphylococcus intermedius group (SIG) is a collection of coagulase-positive staphylococci consisting of four distinct species, namely, Staphylococcus cornubiensis, Staphylococcus delphini, Staphylococcus intermedius, and Staphylococcus pseudintermedius SIG members are animal pathogens and rare causes of human infection. Accurate identification of S. pseudintermedius has important implications for interpretation of antimicrobial susceptibility testing data and may be important for other members of the group. Therefore, we sought to evaluate the performance of five commercially available identification platforms with 21 S. delphini isolates obtained from a variety of animal and geographic sources. Here, we show that automated biochemical platforms were unable to identify S. delphini to the species level, a function of its omission from their databases, but could identify isolates to the SIG level with various degrees of success. However, all automated systems misidentified at least one isolate as Staphylococcus aureus One matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) system was able to identify S. delphini to the species level, suggesting that MALDI-TOF MS is the best option for distinguishing members of the SIG. With the exception of S. pseudintermedius, it is unclear if other SIG members should be routinely identified to the species level; however, as our understanding of their role in animal and human diseases increases, it may be necessary and important to do so.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  MALDI-TOF MS; Staphylococcus delphini; Staphylococcus intermedius group; automated biochemical platform; coagulase-positive staphylococci

Mesh:

Year:  2019        PMID: 31413084      PMCID: PMC6813025          DOI: 10.1128/JCM.00721-19

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  Epidemiology, Clinical Characteristics, and Antimicrobial Susceptibility Profiles of Human Clinical Isolates of Staphylococcus intermedius Group.

Authors:  Melanie L Yarbrough; William Lainhart; C A Burnham
Journal:  J Clin Microbiol       Date:  2018-02-22       Impact factor: 5.948

2.  Human infections due to Staphylococcus pseudintermedius, an emerging zoonosis of canine origin: report of 24 cases.

Authors:  R Somayaji; M A R Priyantha; J E Rubin; D Church
Journal:  Diagn Microbiol Infect Dis       Date:  2016-05-12       Impact factor: 2.803

3.  Evaluation of Pyrrolidonyl Arylamidase Activity in Staphylococcus delphini.

Authors:  Samantha T Compton; Stephen A Kania; Amy E Robertson; Sara D Lawhon; Stephen G Jenkins; Lars F Westblade; David A Bemis
Journal:  J Clin Microbiol       Date:  2016-12-21       Impact factor: 5.948

4.  Staphylococcus pseudintermedius can be misdiagnosed as Staphylococcus aureus in humans with dog bite wounds.

Authors:  S Börjesson; E Gómez-Sanz; K Ekström; C Torres; U Grönlund
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-12-23       Impact factor: 3.267

5.  First reported human isolation of Staphylococcus delphini.

Authors:  Reed Magleby; David A Bemis; David Kim; Karen C Carroll; Mariana Castanheira; Stephen A Kania; Stephen G Jenkins; Lars F Westblade
Journal:  Diagn Microbiol Infect Dis       Date:  2019-01-26       Impact factor: 2.803

6.  Species differentiation within the Staphylococcus intermedius group using a refined MALDI-TOF MS database.

Authors:  J Murugaiyan; B Walther; I Stamm; Y Abou-Elnaga; S Brueggemann-Schwarze; S Vincze; L H Wieler; A Lübke-Becker; T Semmler; U Roesler
Journal:  Clin Microbiol Infect       Date:  2014-06-14       Impact factor: 8.067

7.  Multiplex-PCR method for species identification of coagulase-positive staphylococci.

Authors:  Takashi Sasaki; Sae Tsubakishita; Yoshikazu Tanaka; Arihito Sakusabe; Masayuki Ohtsuka; Shintaro Hirotaki; Tetsuji Kawakami; Tsuneo Fukata; Keiichi Hiramatsu
Journal:  J Clin Microbiol       Date:  2010-01-06       Impact factor: 5.948

8.  Canine Staphylococcus pseudintermedius sinonasal infection in human hosts.

Authors:  Edward C Kuan; Alexander J Yoon; Tara Vijayan; Romney M Humphries; Jeffrey D Suh
Journal:  Int Forum Allergy Rhinol       Date:  2016-02-16       Impact factor: 3.858

9.  Evaluation of Oxacillin and Cefoxitin Disk and MIC Breakpoints for Prediction of Methicillin Resistance in Human and Veterinary Isolates of Staphylococcus intermedius Group.

Authors:  M T Wu; C-A D Burnham; L F Westblade; J Dien Bard; S D Lawhon; M A Wallace; T Stanley; E Burd; J Hindler; R M Humphries
Journal:  J Clin Microbiol       Date:  2015-11-25       Impact factor: 5.948

10.  Antimicrobial resistance among pathogenic bacteria from mink (Neovison vison) in Denmark.

Authors:  Nanett Kvist Nikolaisen; Desireé Corvera Kløve Lassen; Mariann Chriél; Gitte Larsen; Vibeke Frøkjær Jensen; Karl Pedersen
Journal:  Acta Vet Scand       Date:  2017-09-13       Impact factor: 1.695

View more
  1 in total

1.  Characterization of Staphylococcus intermedius Group Isolates Associated with Animals from Antarctica and Emended Description of Staphylococcus delphini.

Authors:  Veronika Vrbovská; Ivo Sedláček; Michal Zeman; Pavel Švec; Vojtěch Kovařovic; Ondrej Šedo; Monika Laichmanová; Jiří Doškař; Roman Pantůček
Journal:  Microorganisms       Date:  2020-02-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.